Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review

BackgroundWe aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL).Research design and methodsWe searched eligible publications up to January 31s...

詳細記述

書誌詳細
主要な著者: Linyan Tian, Cheng Li, Juan Sun, Yixin Zhai, Jinhuan Wang, Su Liu, Yanan Jiang, Wenqi Wu, Donghui Xing, Yangyang Lv, Jing Guo, Hong Xu, Huimeng Sun, Yuhang Li, Lanfang Li, Zhigang Zhao
フォーマット: 論文
言語:English
出版事項: Frontiers Media S.A. 2023-01-01
シリーズ:Frontiers in Immunology
主題:
R/R DLBCL
CAR-T cell
auto-HSCT
survival
meta-analysis
オンライン･アクセス:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041177/full

インターネット

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041177/full

類似資料